Hanmi Science Co., Ltd. (KRX:008930)

Hanmi Science Revenue

Hanmi Science had revenue of 367.86B KRW in the quarter ending June 30, 2026, with 8.75% growth. This brings the company's total for the last twelve months to 1.41T, up 10.00% year-over-year. In the year 2025, Hanmi Science had annual revenue of 1.36T with 5.73% growth. That makes Hanmi Science the 7,345th largest company in the world by revenue and 330th in South Korea.

• Revenue (ttm): 1.41T
• Revenue Growth: +10.00%
• P/S Ratio: 1.99
• Revenue / Employee: 2.86B
• Employees: 493
• Market Cap: 2.83T

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical Wholesale Division 1.14T 81.9%
• Healthcare Business Division 155.11B 11.2%
• Holding Company Division 76.35B 5.5%
• Other Categories 19.44B 1.4%

By Geography

Chart

• South Korea 1.32T 97.4%
• China 33.84B 2.5%
• Other 1.02B 0.1%

Fiscal year ended Dec 31, 2025 See the full Hanmi Science breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.36T	73.53B	5.73%
Dec 31, 2024	1.28T	35.53B	2.85%
Dec 31, 2023	1.25T	201.85B	19.30%
Dec 31, 2022	1.05T	95.89B	10.09%
Dec 31, 2021	950.16B	92.78B	10.82%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error